methyl 5-aminolevulinate has been researched along with bibw 2992 in 1 studies
| Studies (methyl 5-aminolevulinate) | Trials (methyl 5-aminolevulinate) | Recent Studies (post-2010) (methyl 5-aminolevulinate) | Studies (bibw 2992) | Trials (bibw 2992) | Recent Studies (post-2010) (bibw 2992) |
|---|---|---|---|---|---|
| 524 | 152 | 319 | 1,044 | 147 | 1,007 |
| Protein | Taxonomy | methyl 5-aminolevulinate (IC50) | bibw 2992 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.0361 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.0168 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.037 | |
| Cytochrome P450 2E1 | Homo sapiens (human) | 0.014 | |
| Cytochrome P450 2C8 | Homo sapiens (human) | 0.037 | |
| Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | 0.0007 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.037 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.0016 | |
| Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | 0.0024 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cinelli, E; Donnarumma, M; Fabbrocini, G; Panariello, L | 1 |
1 other study(ies) available for methyl 5-aminolevulinate and bibw 2992
| Article | Year |
|---|---|
Case series showing the efficacy of 5-aminolaevulinic acid photodynamic therapy for epidermal growth factor receptor inhibitor-induced paronychia and pyogenic granuloma-like lesions.
Topics: Administration, Topical; Afatinib; Aged; Aminolevulinic Acid; ErbB Receptors; Female; Follow-Up Studies; Granuloma, Pyogenic; Humans; Male; Middle Aged; Neoplasms; Paronychia; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Protein Kinase Inhibitors; Treatment Outcome | 2019 |